A statistical signalling model for use in surveillance of adverse drug reaction data

Journal of Applied Statistics

Volumn 25, Issue 1, 1998, Pages 23-40

  Hillson, Eric M ^a   Reeves, Jaxk H ^b   McMillan, Charlotte A ^c  

^a Astra Merck   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c WYETH AYERST RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007764239     PISSN: 02664763     EISSN: None     Source Type: Journal    
DOI: 10.1080/02664769823287     Document Type: Article

References (18)

1. CASE, R. L. & GUZETTI, P. J. (1986) A survey of adverse drug reaction programs in selected hospitals, Hospital Pharmacy, 21, pp. 423-426, 431-434, 438.
2. FAICH, G. A. (1986) Special report, adverse-drug-reaction monitoring, New England Journal of Medicine, 14, pp. 1589-1592.
3. FDA (1985) Federal Register, 50 (Federal Drug Administration).
4. FLETCHER, A. P. & GRIFFIN, J. P. (1991) International monitoring for adverse drug reactions of long latency, Adverse Drug Reactions and Toxicology Review, 10, pp. 209-230.
5. GRIFFIN, J. P. & WEBBER, J. C. P. (1985) Voluntary systems of adverse reaction reporting Parts I, II, III, Adverse Drug Reactions and Acute Poisoning Review, 4, pp. 183-215.
6. GUESS, H. A. (1989) Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time, Journal of Clinical Epidemiology, 42, pp. 1179-1184.
7. HERMAN, R. L. (1991) Opening remarks, Drug Information Journal, 25, p. 163.
8. HOFFMAN, R. P. (1989) Adverse drug reaction reporting - problems and solutions, Journal of the Michigan Pharmacist, 27, pp. 400-408.
9. JOHNSON, N. L. & KOTZ, S. (1969) Discrete Distributions, Chapter 4 (New York, Wiley).
10. JOHNSON, J. M., TANNER, L. A. & BARASH, D. (1993) The evaluation of postmarketing adverse drug experience reports at FDA: Part I, Drug Information Journal, 27, pp. 1159-1165.
11. KHEIFETS, L. I. (1993) Cluster analysis: a perspective, Statistics in Medicine, 12, pp. 1755-1756.
12. LEHMANN, E. L. (1986) Testing Statistical Hypotheses, 2nd Edn (New York, Wiley).
13. NORWOOD, P. K. & SAMPSON, A. R. (1988) A statistical methodology for postmarketing surveillance of adverse drug reaction reports, Statistics in Medicine, 7, pp. 1023-1030.
14. ROSSI, A. C., Bosco, L., FAICH, G. A., TANNER, A. & TEMPLE, R. (1988) The importance of adverse reaction reporting by physicians - Suprofen and the flank pain syndrome, Journal of the American Medical Association, 259, pp. 1203-1204.
15. SEEGER, J. D., SCHUMOCK, G. T. & KONG, S. X. (1996) Estimating the rate of adverse drug reactions with capture-recapture analysis, American Journal of Health-System Pharmacy, 53, pp. 178-181.
16. THORNTON, J. P. (1988) Adverse drug reaction reporting, Hospital Pharmacy, 23, pp. 489-491.
17. Tsong, Y. (1992) False alarm rates of statistical methods used in determining increased frequency of reports on adverse drug reaction, Journal of Biopharmaceutical Statistics, 2, pp. 9-30.
18. WALLER, P. C. (1991) Postmarketing surveillance: the viewpoint of a newcomer to pharmacopeidemiol-ogy, Drug Information Journal, 25, pp. 181-186.